2fcz
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:2fcz.gif|left|200px]] | + | [[Image:2fcz.gif|left|200px]] |
- | + | ||
- | '''HIV-1 DIS kissing-loop in complex with ribostamycin''' | + | {{Structure |
+ | |PDB= 2fcz |SIZE=350|CAPTION= <scene name='initialview01'>2fcz</scene>, resolution 2.01Å | ||
+ | |SITE= | ||
+ | |LIGAND= <scene name='pdbligand=K:POTASSIUM+ION'>K</scene> and <scene name='pdbligand=RIO:RIBOSTAMYCIN'>RIO</scene> | ||
+ | |ACTIVITY= | ||
+ | |GENE= | ||
+ | }} | ||
+ | |||
+ | '''HIV-1 DIS kissing-loop in complex with ribostamycin''' | ||
+ | |||
==Overview== | ==Overview== | ||
Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
- | 2FCZ is a [ | + | 2FCZ is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FCZ OCA]. |
==Reference== | ==Reference== | ||
- | Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell., Ennifar E, Paillart JC, Bodlenner A, Walter P, Weibel JM, Aubertin AM, Pale P, Dumas P, Marquet R, Nucleic Acids Res. 2006 May 5;34(8):2328-39. Print 2006. PMID:[http:// | + | Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell., Ennifar E, Paillart JC, Bodlenner A, Walter P, Weibel JM, Aubertin AM, Pale P, Dumas P, Marquet R, Nucleic Acids Res. 2006 May 5;34(8):2328-39. Print 2006. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16679451 16679451] |
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
[[Category: Dumas, P.]] | [[Category: Dumas, P.]] | ||
Line 19: | Line 28: | ||
[[Category: RIO]] | [[Category: RIO]] | ||
[[Category: aminoglycoside]] | [[Category: aminoglycoside]] | ||
- | [[Category: | + | [[Category: antibiotic]] |
[[Category: hiv-1]] | [[Category: hiv-1]] | ||
[[Category: rna]] | [[Category: rna]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 16:50:54 2008'' |
Revision as of 14:50, 20 March 2008
| |||||||
, resolution 2.01Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | and | ||||||
Coordinates: | save as pdb, mmCIF, xml |
HIV-1 DIS kissing-loop in complex with ribostamycin
Overview
The kissing-loop complex that initiates dimerization of genomic RNA is crucial for Human Immunodeficiency Virus Type 1 (HIV-1) replication. We showed that owing to its strong similitude with the bacterial ribosomal A site it can be targeted by aminoglycosides. Here, we present its crystal structure in complex with neamine, ribostamycin, neomycin and lividomycin. These structures explain the specificity for 4,5-disubstituted 2-deoxystreptamine (DOS) derivatives and for subtype A and subtype F kissing-loop complexes, and provide a strong basis for rational drug design. As a consequence of the different topologies of the kissing-loop complex and the A site, these aminoglycosides establish more contacts with HIV-1 RNA than with 16S RNA. Together with biochemical experiments, they showed that while rings I, II and III confer binding specificity, rings IV and V are important for affinity. Binding of neomycin, paromomycin and lividomycin strongly stabilized the kissing-loop complex by bridging the two HIV-1 RNA molecules. Furthermore, in situ footprinting showed that the dimerization initiation site (DIS) of HIV-1 genomic RNA could be targeted by these aminoglycosides in infected cells and virions, demonstrating its accessibility.
About this Structure
2FCZ is a Protein complex structure of sequences from [1]. Full crystallographic information is available from OCA.
Reference
Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell., Ennifar E, Paillart JC, Bodlenner A, Walter P, Weibel JM, Aubertin AM, Pale P, Dumas P, Marquet R, Nucleic Acids Res. 2006 May 5;34(8):2328-39. Print 2006. PMID:16679451
Page seeded by OCA on Thu Mar 20 16:50:54 2008
Categories: Protein complex | Dumas, P. | Ennifar, E. | Marquet, R. | Paillart, J C. | K | RIO | Aminoglycoside | Antibiotic | Hiv-1 | Rna